Emmanuel Chamorey

7.3k total citations
194 papers, 4.2k citations indexed

About

Emmanuel Chamorey is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Emmanuel Chamorey has authored 194 papers receiving a total of 4.2k indexed citations (citations by other indexed papers that have themselves been cited), including 77 papers in Oncology, 68 papers in Pulmonary and Respiratory Medicine and 49 papers in Surgery. Recurrent topics in Emmanuel Chamorey's work include Head and Neck Cancer Studies (38 papers), Reconstructive Surgery and Microvascular Techniques (21 papers) and Breast Cancer Treatment Studies (17 papers). Emmanuel Chamorey is often cited by papers focused on Head and Neck Cancer Studies (38 papers), Reconstructive Surgery and Microvascular Techniques (21 papers) and Breast Cancer Treatment Studies (17 papers). Emmanuel Chamorey collaborates with scholars based in France, United States and Italy. Emmanuel Chamorey's co-authors include O. Dassonville, Alexandre Bozec, Gilles Poissonnet, F Démard, F. Ettore, Karen Bénézery, Jean-­Marc Ferrero, Anne Sudaka, Jean‐Michel Hannoun‐Lévi and Frédéric Peyrade and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Emmanuel Chamorey

184 papers receiving 4.1k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Emmanuel Chamorey 1.6k 1.2k 1.1k 882 776 194 4.2k
Heather Lin 2.2k 1.3× 1.6k 1.4× 949 0.8× 1.0k 1.1× 1.3k 1.6× 173 4.9k
Douglas B. Flieder 2.0k 1.2× 2.6k 2.2× 839 0.7× 555 0.6× 801 1.0× 86 5.2k
Francesca De Felice 1.4k 0.9× 957 0.8× 919 0.8× 378 0.4× 578 0.7× 214 3.6k
Melvin L.K. Chua 2.3k 1.4× 1.1k 0.9× 760 0.7× 742 0.8× 842 1.1× 167 5.1k
R. Swindell 2.3k 1.4× 1.8k 1.5× 1.5k 1.3× 997 1.1× 848 1.1× 166 6.1k
Yuanyuan Zhao 1.9k 1.1× 1.1k 0.9× 475 0.4× 533 0.6× 558 0.7× 162 3.0k
Kumar Prabhash 2.5k 1.5× 2.6k 2.2× 1.2k 1.0× 702 0.8× 816 1.1× 531 5.5k
Liz Kenny 1.3k 0.8× 1.1k 1.0× 748 0.7× 982 1.1× 793 1.0× 136 4.0k
Jin‐Ching Lin 1.8k 1.1× 908 0.8× 1.5k 1.3× 721 0.8× 764 1.0× 106 4.0k
Brett Hughes 2.3k 1.4× 2.1k 1.8× 375 0.3× 696 0.8× 820 1.1× 179 4.4k

Countries citing papers authored by Emmanuel Chamorey

Since Specialization
Citations

This map shows the geographic impact of Emmanuel Chamorey's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emmanuel Chamorey with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emmanuel Chamorey more than expected).

Fields of papers citing papers by Emmanuel Chamorey

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Emmanuel Chamorey. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emmanuel Chamorey. The network helps show where Emmanuel Chamorey may publish in the future.

Co-authorship network of co-authors of Emmanuel Chamorey

This figure shows the co-authorship network connecting the top 25 collaborators of Emmanuel Chamorey. A scholar is included among the top collaborators of Emmanuel Chamorey based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Emmanuel Chamorey. Emmanuel Chamorey is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Rubera, Isabelle, Christophe Duranton, Jocelyn Gal, et al.. (2025). The PROPHECI trial: a phase II, double-blind, placebo-controlled, randomized clinical trial for the treatment of pseudoxanthoma elasticum with oral pyrophosphate. Trials. 26(1). 30–30. 3 indexed citations
3.
Hébert, Christophe, Jean-­Marc Ferrero, Véronique Mari, et al.. (2025). EMOTION: Assessing the Impact of a Telephone Intervention for Patients With Breast Cancer, a Randomized Controlled Trial. JCO Oncology Practice. 22(3). 474–483.
4.
Hofman, Véronique, Emmanuel Chamorey, Renaud Schiappa, et al.. (2024). Reproducibility of c-Met Immunohistochemical Scoring (Clone SP44) for Non–Small Cell Lung Cancer Using Conventional Light Microscopy and Whole Slide Imaging. The American Journal of Surgical Pathology. 48(9). 1072–1081. 1 indexed citations
5.
Chamorey, Emmanuel, Jean-­Marc Ferrero, Hakim Mahammedi, et al.. (2024). Long-Term Pharmacokinetic Follow-Up of Abiraterone Acetate in Patients with Metastatic Castration-Resistant Prostate Cancer. International Journal of Molecular Sciences. 25(11). 6058–6058.
6.
Bailleux, Caroline, Jocelyn Gal, Emmanuel Chamorey, Baharia Mograbi, & G. Milano. (2024). Artificial Intelligence and Anticancer Drug Development—Keep a Cool Head. Pharmaceutics. 16(2). 211–211. 8 indexed citations
7.
Chamorey, Emmanuel, Jocelyn Gal, Baharia Mograbi, & G. Milano. (2024). Critical Appraisal and Future Challenges of Artificial Intelligence and Anticancer Drug Development. Pharmaceuticals. 17(7). 816–816. 2 indexed citations
8.
Culié, Dorian, et al.. (2024). Enhancing Thyroid Pathology With Artificial Intelligence: Automated Data Extraction From Electronic Health Reports Using RUBY. JCO Clinical Cancer Informatics. 8(8). e2300263–e2300263. 1 indexed citations
9.
Gal, Jocelyn, Emmanuel Chamorey, O. Dassonville, et al.. (2023). Docetaxel-Cisplatin-Fluorouracil Induction Chemotherapy for Larynx Preservation in Patients with Locally Advanced Hypopharyngeal Cancer: Predictive Factors of Oncologic and Functional Outcomes. Journal of Clinical Medicine. 12(3). 1131–1131. 3 indexed citations
10.
Gal, Jocelyn, Emmanuel Chamorey, Renaud Schiappa, et al.. (2023). Salvage vs. Primary Total Laryngectomy in Patients with Locally Advanced Laryngeal or Hypopharyngeal Carcinoma: Oncologic Outcomes and Their Predictive Factors. Journal of Clinical Medicine. 12(4). 1305–1305. 8 indexed citations
11.
Gal, Jocelyn, O. Dassonville, Clair Vandersteen, et al.. (2023). Application of machine learning methods to guide patient management by predicting the risk of malignancy of Bethesda III-V thyroid nodules. European Journal of Endocrinology. 188(3). 249–257. 8 indexed citations
12.
Schiappa, Renaud, Dorian Culié, Jocelyn Gal, et al.. (2023). Validation of RUBY for Breast Cancer Knowledge Extraction From a Large French Electronic Medical Record System. JCO Clinical Cancer Informatics. 7(7). e2200130–e2200130. 3 indexed citations
13.
14.
Milano, G., et al.. (2021). Myocarditis and COVID-19 Mrna Vaccines: A Mechanistic Hypothesis Involving dsRNA. Future Virology. 17(3). 191–196. 25 indexed citations
15.
16.
Montemagno, Christopher, Delphine Borchiellini, Olivia Rastoin, et al.. (2020). Soluble forms of PD-L1 and PD-1 as prognostic and predictive markers of sunitinib efficacy in patients with metastatic clear cell renal cell carcinoma. OncoImmunology. 9(1). 1846901–1846901. 35 indexed citations
17.
Culié, Dorian, R. Garrel, Julien Viotti, et al.. (2018). Impact of HPV-associated p16-expression and other clinical factors on therapeutic decision-making in patients with oropharyngeal cancer: A GETTEC multicentric study. European Journal of Surgical Oncology. 44(12). 1908–1913. 8 indexed citations
18.
Dadone, Bérengère, Damien Ambrosetti, C. Baudoin, et al.. (2015). Dismantling papillary renal cell carcinoma classification: The heterogeneity of genetic profiles suggests several independent diseases. Genes Chromosomes and Cancer. 54(6). 369–382. 32 indexed citations
19.
Grépin, Renaud, Mélanie Guyot, Sandy Giuliano, et al.. (2013). The CXCL7/CXCR1/2 Axis Is a Key Driver in the Growth of Clear Cell Renal Cell Carcinoma. Cancer Research. 74(3). 873–883. 80 indexed citations
20.
Marcy, Pierre‐Yves, et al.. (2010). Central and peripheral venous port catheters: evaluation of patients? satisfaction under local anesthesia and Author's reply. The Journal of Vascular Access. 11(2). 177–178. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Heather Lin Breakdown of academic impact, for papers by Douglas B. Flieder Breakdown of academic impact, for papers by Francesca De Felice Breakdown of academic impact, for papers by Melvin L.K. Chua Breakdown of academic impact, for papers by R. Swindell Breakdown of academic impact, for papers by Yuanyuan Zhao Breakdown of academic impact, for papers by Kumar Prabhash Breakdown of academic impact, for papers by Liz Kenny Breakdown of academic impact, for papers by Jin‐Ching Lin Breakdown of academic impact, for papers by Brett Hughes
Rankless by CCL
2026